摘要
目的:探讨急性心肌梗死(AMI)后不同时间溶栓治疗对血管再通的影响。方法:回顾性分析96例AMI患者的溶栓疗效,根据发病后时间溶栓分为0~3h,>3~6h,>6~12h三组。结果:三组血管再通率分别为86.96%、74.51%、61.91%。早期治疗(0~6h)组血管再通率(78.38%)与延迟治疗(>6~12h)组的61.91%相比较,差异有显著性意义(P<0.05);两组五周病死率、反复心绞痛和反复Ⅱ度以上房室传导阻滞(AVB)相比,差异显著(P<0.01)。结论:AMI发病后6h内溶栓治疗,血管再通效果最好,住院病死率最低,但发病时间>6~12h的溶栓治疗仍可取得较好的效果。
Objective: To investigate the effect of revasculafization in the different time after acute myocardial infarction (AMI) treated by thrombolysis. Methods: The 96 AMI patients were divided into three groups according to thrombolytie time after AMI:0-3 h, 〉 3-6 h, 〉 6-12 h. Results: The reopen rate of blood vessel was 86.96%, 74.51% and 61.91% in the three groups respectively. The difference in the reopen rate of blood vessel between earlier therapy (0-6 h) and delayed therapy ( 〉 6-12 h) was significant (78.38%, 61.91%, P 〈 0.05), the difference of mortality, repeating angina pectoris, 1I degree atrioventricular block during 5 weeks between these two groups were highly significant (P 〈 0.01). Conclusion: Thrombolytie therapy in 6 hours after AMI has better effect but delayed therapy (〉 6-12 h) still has moderate effect.
出处
《岭南急诊医学杂志》
2007年第1期11-12,共2页
Lingnan Journal of Emergency Medicine
关键词
急性心肌梗死
溶栓疗法
尿激酶
acute myocardial infarction
thrombolytie therapy
Urokinase